This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Expiration Date: 7/18/2020
Intravitreal therapy has rapidly evolved to become a mainstay of treatment for many retinal diseases, offering delayed or arrested disease progression and the…go to activity»
This activity is supported by independent medical education grants from Optos North America and Regeneron Pharmaceuticals, Inc.
Expiration Date: 6/1/2020
Diabetic retinopathy (DR) continues to be a leading cause of blindness. However, early diagnosis and prompt treatment with laser and/or intravitreal anti-vascular…go to activity»
This activity is produced by SLACK Incorporated and sponsored by Alcon.
June 11, 2019
Cataract surgeons have used the IOL platforms they believe to provide the best possible visual outcomes for their patients. Although IOLs are typically reliable and…go to activity»
Sponsored by Alcon
June 10, 2019
During Hawaiian Eye 2019, key opinion leaders gathered for an Industry Expert Theater panel discussion, sponsored by Alcon, to discuss the future technological…go to activity»
This activity is supported by educational grants from Alcon Laboratories, Inc. and EyePoint Pharmaceuticals, Inc.
Expiration Date: 5/25/2020
New techniques for cataract surgery have emerged in rapid succession over the past few years. Some of these techniques have been demonstrated to provide clinically…go to activity»
This activity is supported by an educational grant from Genentech, Inc.
Expiration Date: 5/2/2020
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy has revolutionized the treatment of age-related macular degeneration (AMD), but it has…go to activity»